David Aaron Lehman's Net Worth

$12.3 Million

Estimate Recalculated Nov 1, 2024 05:03AM EST

Who is David Aaron Lehman?

David Aaron Lehman has an estimated net worth of $12.3 Million. This is based on reported shares across multiple companies, which include THORATEC CORP, Pulmonx Corp, and Intersect ENT, Inc..

SEC CIK

David Aaron Lehman's CIK is 0001354228

Past Insider Trading and Trends

2012 was David Aaron Lehman's most active year for acquiring shares with 7 total transactions. David Aaron Lehman's most active month to acquire stocks was the month of February. 2008 was David Aaron Lehman's most active year for disposing of shares, totalling 12 transactions. David Aaron Lehman's most active month to dispose stocks was the month of February. 2017 saw David Aaron Lehman paying a total of $648,000.00 for 87,000 shares, this is the most they've acquired in one year. In 2015 David Aaron Lehman cashed out on 248,792 shares for a total of $10,546,072.52, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

THORATEC CORP No price found

SVP and General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-54.77K
$63.50
-$4,550,092.50
0
Oct 1 - Oct 8
Form 4
-1.64%
-914.00
$40.24
-$36,779.36
54.77K
Mar 17
Form 4
+29.43%
12.66K
—
—
55.69K
Mar 16
Form 4
-4.88%
-2.21K
$39.61
-$87,379.66
43.03K
Mar 9
Form 4
-2.66%
-1.24K
$40.25
-$49,829.50
45.23K
Mar 2
Form 4
+26.44%
9.72K
—
—
46.47K
Mar 17
Form 4
-7.86%
-3.14K
$36.82
-$115,451.94
36.75K
Mar 7 - Mar 10
Form 4
-7.40%
-3.19K
$36.24
-$115,569.36
39.89K
Mar 3
Form 4
-12.03%
-5.89K
$28.04
-$548,884.03
43.08K
Scheduled
Oct 11
Form 4
+0.16%
80
$33.62
-$2,958.56
48.97K
May 15
Form 4
+25.31%
9.87K
$35.79
-$56,333.46
48.89K
Mar 7 - Mar 11
Form 4
-7.30%
-3.07K
$35.29
-$108,324.99
39.01K
Mar 1 - Mar 4
Form 4
-2.96%
-1.28K
$35.57
-$45,636.31
42.08K
Feb 25
Form 4
—
0
$29.20
-$232,540.87
43.37K
Scheduled
Jan 2
Form 4
—
0
$28.27
-$160,490.03
43.37K
Scheduled
Dec 27
Form 4
-8.30%
-3.92K
$24.28
-$339,886.56
43.37K
Scheduled
Oct 4
Form 4
—
0
$24.23
-$38,255.27
47.29K
Scheduled
Sep 7
Form 4
-7.87%
-4.04K
$24.23
-$380,860.07
47.29K
Scheduled
Jul 17
Form 4
+30.72%
12.06K
—
—
51.33K
Mar 9
Form 4
-6.59%
-2.77K
$34.23
-$94,860.32
39.26K
Mar 1 - Mar 5
Form 4
-5.45%
-2.42K
$35.53
-$86,160.25
42.03K
Feb 27
Form 4
+31.42%
10.63K
$28.93
-$39,634.10
44.46K
Mar 1 - Mar 3
Form 4
-6.46%
-2.33K
$27.88
-$65,089.29
33.83K
Feb 25 - Feb 28
Form 4
-2.68%
-1.00K
$27.15
-$27,068.55
36.16K
Feb 14
Form 4
—
0
$28.35
-$1,669,704.87
37.16K
Scheduled
Jun 3
Form 4
+46.15%
11.73K
—
—
37.16K
Mar 3
Form 4
-4.81%
-1.28K
$28.89
-$37,094.76
25.43K
Mar 1
Form 4
-6.23%
-1.77K
$28.58
-$50,724.13
26.71K
Feb 24 - Feb 25
Form 4
-3.59%
-1.06K
$28.94
-$30,734.28
28.49K
Feb 16
Form 4
-4.09%
-1.26K
$22.84
-$28,755.56
29.55K
Feb 27
Form 4
+36.86%
8.3K
$25.08
-$17,631.24
30.81K
Feb 24 - Feb 25
Form 4
-4.43%
-1.04K
$27.35
-$28,526.05
22.51K
Feb 13
Form 4
—
0
$19.18
-$305,999.32
23.55K
Aug 28
Form 4
+0.27%
64
$16.20
-$583.20
23.55K
May 15
Form 4
+88.07%
11K
—
—
23.49K
Feb 27
Form 4
-4.76%
-624.00
$15.26
-$9,522.24
12.49K
Feb 25
Form 4
-6.03%
-841.00
$15.22
-$12,800.02
13.11K
Feb 13
Form 4
-4.26%
-621.00
$20.94
-$13,003.74
13.96K
Feb 26
Form 4
+117.26%
7.87K
—
—
14.58K
Feb 13
Form 4
+667.62%
5.83K
—
—
6.71K
Mar 31
Form 3
—
0
—
—
0
No matching records found

Pulmonx Corp (LUNG) Snapshot price: $7.31

GENERAL COUNSEL

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.76%
-5.76K
$6.69
-$38,576.43
203.35K
Sep 3
Form 4
-2.55%
-5.47K
$6.97
-$38,160.75
209.11K
Jun 3
Form 4/A
+47.50%
69.1K
—
—
214.59K
Mar 1
Form 4
+20.12%
30.15K
$9.06
-$39,420.06
179.99K
Mar 1
Form 4
-2.48%
-3.81K
$10.34
-$39,381.04
149.84K
Dec 1
Form 4
-2.40%
-3.77K
$10.01
-$37,757.72
153.65K
Sep 1
Form 4
-2.34%
-3.78K
$11.48
-$43,348.48
157.42K
Jun 1
Form 4
+265.03%
117.04K
$11.03
-$13,941.92
161.2K
Mar 1
Form 4
-2.36%
-1.07K
$5.93
-$6,339.17
44.16K
Dec 1
Form 4
-2.34%
-1.08K
$17.88
-$19,350.08
45.23K
Sep 1
Form 4
-2.25%
-1.06K
$18.05
-$19,223.25
46.31K
Jun 1
Form 4
+181.43%
30.54K
$25.91
-$11,866.78
47.38K
Mar 1
Form 4
-2.22%
-383.00
$32.73
-$12,535.59
16.83K
Dec 1
Form 4
-2.18%
-383.00
$40.09
-$15,354.47
17.22K
Sep 1
Form 4
∞
17.6K
—
—
17.6K
Jun 1
Form 3
—
0
—
—
0
No matching records found

Intersect ENT, Inc. No price found

EVP & General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+37.21%
21.48K
—
—
79.2K
Feb 3
Form 4
-11.93%
-7.82K
$24.25
-$189,512.58
57.73K
Jan 2 - Jan 6
Form 4
+94.21%
31.79K
—
—
65.54K
Nov 26
Form 4
+54.84%
11.95K
$25.51
-$135,201.60
33.75K
Scheduled
May 6 - May 7
Form 4
—
0
$25.52
-$135,342.90
21.8K
Scheduled
Apr 29
Form 4
+70.34%
9K
—
—
21.8K
Jan 16
Form 4
-15.89%
-2.42K
$26.57
-$64,240.21
12.79K
Jan 1
Form 4
+97.24%
7.5K
—
—
15.21K
Jan 17
Form 4
-14.30%
-1.29K
$33.93
-$43,671.51
7.71K
Jan 1
Form 4
—
0
$25.38
-$531,000.00
9K
Scheduled
Dec 11
Form 4
∞
9K
—
—
9K
Jan 18
Form 4
—
0
—
—
0
Feb 22
Form 3
—
0
—
—
0
No matching records found